Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

LY 171883

Leukotriene D4 antagonist
 
BML-RA101-0010 10 mg 84.00 USD
 
BML-RA101-0050 50 mg 277.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-340-026

Selective, orally active leukotriene D4 antagonist. Has been shown to bind to the γ-isoform of the peroxisome proliferator-activated receptor (PPARγ).

Product Specification

Alternative Name:Tomelukast
 
Formula:C16H22N4O3
 
MW:318.4
 
CAS:88107-10-2
 
Purity:≥90% (HPLC)
 
Appearance:White solid.
 
MeltingPoint:117-119°C
 
Solubility:Soluble in DMSO (25mg/ml), 100% ethanol (25mg/ml) or dimethyl formamide. Also soluble in 0.5M aqueous sodium bicarbonate.
 
Shipping:Ambient
 
Long Term Storage:Ambient
 
Use/Stability:Organic stock solutions are stable for at least six months when stored at -20°C.
 
Regulatory Status:RUO - Research Use Only
 
BML-RA101 structure
Please mouse over
BML-RA101 structure

Product Literature References

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma: B.M. Forman, et al.; Cell 83, 803 (1995), Abstract;
Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor: P. Tontonoz, et al.; Cell 79, 1147 (1994), Abstract;
Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit: A. Sala, et al.; Br. J. Pharmacol. 110, 1206 (1993), Abstract;
In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist: D.W. Snyder, et al.; J. Pharmacol. Exp. Ther. 243, 548 (1987), Abstract;
LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist: J.H. Fleisch, et al.; J. Pharmacol. Exp. Ther. 233, 148 (1985), Abstract;

Recommend this page

 
Keep in touch

©2020 Enzo Life Sciences, Inc.,